FDA grants Neuros Medical IDE approval to conduct clinical trial for pain management technology for amputees

FDA grants Neuros Medical IDE approval to conduct clinical trial for pain management technology for amputees

October 10, 2013 2:38 pm by | 0 Comments

Neuros Medical, a Cleveland-based medical device company, received an FDA investigational device exemption approval to begin a clinical study on its technology for intractable limb pain management for amputees. According…


Pain device maker Neuros Medical’s $3.5M round led by Boston Scientific, Glengary

Pain device maker Neuros Medical’s $3.5M round led by Boston Scientific, Glengary

July 18, 2012 4:41 pm by | 0 Comments

Neurostimulation device company Neuros Medical Inc. has landed $3.5 million in its second round of funding from a handful of investors including medical device powerhouse Boston Scientific (NYSE:BSX). The company’s…



Chronic pain device from Neuros Medical gets new investor

Chronic pain device from Neuros Medical gets new investor

February 14, 2012 1:37 pm by | 0 Comments

Neurostimulation startup Neuros Medical, which is developing a device to block the chronic pain of amputees, has secured a new investor in RiverVest Venture Partners. RiverVest will participate in Neuros’…


Neuros Medical gets regulatory OK for pilot clinical trial

Neuros Medical gets regulatory OK for pilot clinical trial

November 28, 2011 2:37 pm by | 0 Comments

Neurostimulation startup Neuros Medical has received regulatory approval to begin a pilot clinical trial of its device that blocks pain experienced by amputees. Receiving Investigational Device Exemption (IDE) approval from…


Neuros Medical looks to close $3.5M round, begin pilot clinical study

Neuros Medical looks to close $3.5M round, begin pilot clinical study

October 31, 2011 11:57 am by | 0 Comments

Neurostimulation company Neuros Medical is looking to collect a $3.5 million round of investment that it would use to launch a pilot study of its pain-relief device. After earlier this…


Neuros Medical reports positive results from study of pain-blocking device

Neuros Medical reports positive results from study of pain-blocking device

April 6, 2011 11:45 am by | 0 Comments

Neurotechnology startup Neuros Medical reported encouraging results from the first in-human study of its device that blocks pain for amputation patients. The Willoughby, Ohio, company said that four of five…


Neuros Medical reports early results from study of pain-blocking device

Neuros Medical reports early results from study of pain-blocking device

January 18, 2011 11:14 am by | 0 Comments

Neuros Medical announced positive early results in the first-ever in-human feasibility study of its pain-blocking device.



A look at Northeast Ohio’s growing neurotechnology industry

A look at Northeast Ohio’s growing neurotechnology industry

January 13, 2011 10:53 am by | 0 Comments

Cleveland Clinic neuromodulation spinoff Intelect Medical may have stealthily exited Cleveland to set up shop in Boston, but the company’s recent $78 million sale to Boston Scientific (NYSE: BSX) highlights Northeast Ohio’s growing strength in neurotechnology. Here’s a brief overview of the key players in Northeast Ohio’s rising neurotechnology industry.


Neuros Medical adds former J&J, St. Jude executive to board

Neuros Medical adds former J&J, St. Jude executive to board

July 12, 2010 9:22 am by | 0 Comments

Neuros Medical Inc. has added a medical device industry veteran to its board of directors. Scott Drees joins the board as an independent director, according to a statement from Neuros….


Neuros Medical gets $1.5M defense award for pain-blocking device

Neuros Medical gets $1.5M defense award for pain-blocking device

July 2, 2010 3:01 pm by | 0 Comments

Neuros Medical Inc. plans to double — maybe even triple — its employment over the coming year as it uses a $1.5 million U.S. Department of Defense grant to speed…


Queen City Angels defy bad economy, invest in 8 health care companies

Queen City Angels defy bad economy, invest in 8 health care companies

March 3, 2010 3:02 pm by | 0 Comments

Queen City Angels invested in seven life sciences companies and one health information technology company last year, according to its 2009 annual operating report (pdf). The group of accredited investors…


Neuros Medical chooses Battelle to co-develop neurostimulation device for chronic pain

Neuros Medical chooses Battelle to co-develop neurostimulation device for chronic pain

December 7, 2009 2:01 pm by | 0 Comments

Neuros Medical Inc. has chosen Battelle to help develop its neurostimulation device to block chronic pain. Neuros Medical is developing a “nerve block” system that stimulates nerves to block pain.


Fresh from fundraising, Neuros Medical hires chief technology officer, appoints clinical advisers

Fresh from fundraising, Neuros Medical hires chief technology officer, appoints clinical advisers

November 10, 2009 3:30 pm by | 0 Comments

Fresh from its first round of fundraising, neurostimulation device developer Neuros Medical Inc. has hired a chief technology officer and appointed a board of advisers.


Neurostimulation device developer Neuros Medical Inc. wins $1.8 million from investors

Neurostimulation device developer Neuros Medical Inc. wins $1.8 million from investors

October 23, 2009 10:16 am by | 0 Comments

Neuros Medical Inc., a start-up company that is developing a neurostimulation device to block chronic pain, has landed $1.8 million from several investors during its first round of venture financing. Neuros Medical will use the money to begin product development, hire a chief technology officer and complete clinical studies on its device that stimulates nerves to alleviate pain.


Neuros Medical launches to develop new device to block amputee, chronic pain

Neuros Medical launches to develop new device to block amputee, chronic pain

March 16, 2009 11:01 pm by | 4 Comments

Neuros Medical on Monday closed on $375,000 in funding from JumpStart and Case Technology Ventures. Its medical device would use high-frequency neurostimulation to solve untreated amputee pain with the hope it could be used for other types of chronic pain. Researchers are completing animal trials now, and the funding will be used to launch human trials later this year.